BMO Capital raised the firm’s price target on AMN Healthcare (AMN) to $25 from $22 and keeps an Outperform rating on the shares. The firm is adjusting its estimates after the management disclosed its updated expectations for 2026 and beyond at the JP Morgan Healthcare Conference, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMN: